Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma
- Citation:
- Blood Adv vol 7 (11) 2287-96
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-external-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Not reviewed; Alliance NCTN grant not added.
- Corr. Author:
- Authors:
- Narendranath Epperla Jeffrey Switchenko Veronika Bachanova James N. Gerson Stefan K. Barta Max J. Gordon Alexey V. Danilov Natalie S. Grover Stephanie Mathews Madelyn Burkart Reem Karmali Yazeed Sawalha Brian T. Hill Nilanjan Ghosh Steven I. Park David A. Bond Mehdi Hamadani Timothy S. Fenske Peter Martin Mary-Kate Malecek Brad S. Kahl Christopher R. Flowers Brian K. Link Lawrence D. Kaplan David J. Inwards Andrew L. Feldman Eric D. Hsi Kami Maddocks Kristie A. Blum Nancy L. Bartlett James R. Cerhan John P. Leonard Thomas M. Habermann Matthew J. Maurer Jonathon B. Cohen
- Networks:
- Study
- Alliance-A152021
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-50403
- Phases:
- N/A, 2
- Keywords: